MedTrace Logo

Implementation of a Pain Management Protocol for Total Knee Arthroplasty

NCT02474654 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2019-01-18

No results posted yet for this study

Summary

Study question: Is there an ideal combination of intraoperative long acting analgesics (periarticular infiltration (PI), femoral nerve block (FB) and intrathecal opioids (IO)) to optimize post-operative functional recovery, decrease overall narcotic consumption and enable faster 'readiness to discharge' for patients undergoing primary total knee replacement (TKR)?

Conditions

  • Knee Replacement, Total

Interventions

DRUG

Bupivicaine

15mg

DRUG

Fentanyl

15mcg

DRUG

Epimorphine

150mcg

DRUG

Normal Saline

0.3 ml

DRUG

Normal Saline

30ml

DRUG

Normal Saline

100 ml

DRUG

Ropivicaine

100 ml

DRUG

Epinephrine

600 mcg

DRUG

Ketorolac

30 mg

DRUG

Ropivicaine with Epinephrine

0.5% 1:400,000 30ml

Sponsors & Collaborators

  • Health Sciences North Research Institute

    lead OTHER

Principal Investigators

  • Kim Wong, MD, FRCPC, BSc, PT · Health Sciences North

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2019-01-14
Completion
2019-01-14

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02474654 on ClinicalTrials.gov